Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TeRCC study of temsirolimus in previously treated metastatic renal cell carcinoma
2007-007045-12Phase 2Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temsirolimus in renal cell carcinoma (RCC) and metastatic renal cell carcinoma (mRCC), sponsored by IRCCS San Matteo Foundation. Primary endpoint: response rate. Started Jan 2008; status: terminated.
02
Drugs
temsirolimus
03
Conditions
renal cell carcinoma (RCC)metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on 2007-007045-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007045-12.